ESTHETIC VS. MEDICAL INTERVENTION
BOTOX COSMETIC
DYSPORT
DERMAL FILLERS
SCLEROTHERAPY & MEDICAL PEELS
100

This side of esthetics focuses on services like facials, microdermabrasion, and esthetic peels.

The esthetic side of the field

100

Botox Cosmetic is the brand name for this neurotoxin.

OnabotulinumtoxinA

100

Most Dysport adverse events are associated with treatment of this neuromuscular condition.

Cervical dystonia

100

The three key skin components responsible for youthful fullness and elasticity that decline with age.

Collagen, elastin, and hyaluronic acid

100

Dilated red/blue/purple vessels seen through the skin, often on the lower legs, commonly called this.

Varicose veins (including spider veins)

200

This side of esthetics involves injectable products, vein therapy, and advanced medical peels.

The medical side of esthetics

200

Botox Cosmetic works by temporarily relaxing muscles to reduce this visible sign of aging.

Fine lines and wrinkles

200

According to the manufacturer, adverse events for Dysport generally occur at rates under this percentage.

5 percent

200

This Allergan hyaluronic acid filler uses Hylacross technology and often lasts up to one year.

Juvederm or Juvederm Ultra Plus

200

The more common name for “vein therapy” where a solution is injected to eliminate vessels.

Sclerotherapy

300

Botox Cosmetic, Dysport, dermal fillers, and sclerotherapy fall under this classification.

Medical intervention

300

This facial area is the only FDA-approved cosmetic indication for neurotoxin treatment.

Glabellar frown lines

300

These upper respiratory–type symptoms may occur in fewer than 2 percent of Dysport patients treated for glabellar lines.

Nasopharyngitis or upper respiratory tract infections

300

This rare but serious dermal filler complication occurs when blood supply to the skin is blocked.

Skin necrosis

300

Name one medical reason a client may be disqualified from sclerotherapy.

Circulatory problems or heart disease diabetes, HIV, AIDS, bloodborne disease, anticoagulation therapy

400

Although estheticians cannot perform medical interventions, they often do this first for clients.

Educate, suggest options, or answer client questions.

400

Botox Cosmetic does not cross this protective barrier, which limits its effects to the injection site.

The blood–brain barrier

400

This musculoskeletal complaint may occur following Dysport treatment.

Neck pain or musculoskeletal pain

400

This cosmetic injectable option is often called a “liquid facelift” because it restores volume without surgery.

Dermal fillers

400

This three-acid combo peel is 14%/14%/14% (salicylic/resorcinol/lactic) in ethanol.

Jessner’s solution

500

Estheticians may share general information about injectables but must avoid doing this.  

Diagnosing, prescribing, or guaranteeing results.

500

These muscles are commonly treated in the upper third of the face with neurotoxins.

The frontalis, corrugator supercilii/procerus, and orbicularis oculi

500

This symptom reflects generalized tiredness reported in some Dysport patients.

Fatigue

500

An esthetician’s most important role when a filler complication occurs is to provide reassurance and do this.

Refer the client to the medical provider and stay within scope of practice

500

In sclerotherapy, this type of injectable agent is used to trigger fibrosis and eventual elimination of the vein.

Chemical irritant (sclerosing agent)

M
e
n
u